Results 51 to 60 of about 834 (96)

Primary cutaneous plasmacytosis successfully treated with topical corticosteroids and psoralen plus ultraviolet A: A case report

open access: yesClinical Case Reports
Key clinical message We present a case of primary cutaneous plasmacytosis without systemic involvement. The patient received topical corticosteroids and psoralen plus ultraviolet A therapy, showing significant improvement.
Thanyathorn Nuchanatanon   +2 more
doaj   +1 more source

Non‐Cultured Melanocyte‐Keratinocyte Transplantation Combined With NB‐UVB Therapy for Facial Depigmentation Induced by Skin Exfoliator: A Case Report

open access: yesClinical Case Reports
Non‐cultured melanocyte‐keratinocyte transplantation combined with narrowband ultraviolet B (NB‐UVB) therapy is a promising and well‐tolerated treatment for facial hypo‐pigmentation following scarring.
Sona Zare   +4 more
doaj   +1 more source

Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients

open access: yesTherapeutics and Clinical Risk Management, 2016
Edyta Katarzyna Głażewska,1 Marek Niczyporuk,1 Sławomir Ławicki,2 Maciej Szmitkowski,2 Monika Zajkowska,2 Grażyna Ewa Będkowska,3 Andrzej Przylipiak1 1Department of Esthetic Medicine, 2Department of Biochemical Diagnostics, 3Department of Haematological
Głażewska EK   +6 more
doaj  

Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study

open access: yesClinical, Cosmetic and Investigational Dermatology
Bin Zhou,1,2 Jiachen Gui,2,3 Tao Wang,2,4 Zhimin Li,2 Wenzhi Hu,5 Yue Zhang,2 Qiang Li2 1Graduate School, Hebei North University, Zhangjiakou, People’s Republic of China; 2Department of Dermatology, Air Force Medical Center, PLA, Beijing, People’s ...
Zhou B   +6 more
doaj  
Some of the next articles are maybe not open access.

Related searches:

Ultraviolet therapy in lupus

Lupus, 2001
This review examines the use of ultraviolet (UV) therapy in lupus erythematosus (LE), a disorder usually associated with abnormally increased photosensitivity. In addition to the abnormal cutaneous response to ultraviolet radiation (UVR) exposure, photo-aggravation of systemic disease activity in systemic LE (SLE) may also occur.
Millard, T P, Hawk, J L M
openaire   +2 more sources

Status of ultraviolet A dosimetry in methoxsalen plus ultraviolet A therapy

Journal of the American Academy of Dermatology, 1986
The carcinogenic risk of methoxsalen plus ultraviolet A treatment (PUVA) is almost certainly related to the cumulative UVA exposure dose. A reliable estimate of UVA dose is a major component, therefore, in determining the long-term safety of this treatment modality.
B L, Diffey, R, Roelandts
openaire   +2 more sources

Psoralens and ultraviolet A therapy of pityriasis lichenoides

Journal of the American Academy of Dermatology, 1984
Three patients with long-standing pityriasis lichenoides, which was resistant to other forms of therapy, were successfully treated with PUVA (psoralens and ultraviolet light of wavelength A). One patient had complete clearing of all lesions, and the other two had marked improvement.
F C, Powell, S A, Muller
openaire   +2 more sources

Ultraviolet Therapy for Psoriasis

2014
Total-body ultraviolet therapy (UV) for moderate-to-severe psoriasis consists of narrowband and broadband-UVB, psoralen plus UVA (PUVA – where psoralen can be ingested orally or applied topically), inpatient phototherapy (i.e. Goeckerman Therapy, Ingram therapy), non-office-based phototherapy (i.e.
Tien V. Nguyen, John Y. M. Koo
openaire   +1 more source

Ultraviolet and laser therapy

2008
Natural sunlight’s beneficial effect on psoriasis has been long known. This observation led over the past century to the utilization of artificial light sources for the treatment of psoriasis. For over seven decades, phototherapy using artificial ultraviolet light has been an established standard in the treatment of psoriasis.
Rahat S. Azfar, Abby S. Van Voorhees
openaire   +1 more source

Home - About - Disclaimer - Privacy